I am an investor

I want to know more about Cantargia's research

I want to know more about Cantargia as a company

CEO presentation

To the presentation (in Swedish)

Presentation at ASCO 2019, follow up articles and interviews

Cantargia interview at EFN after ASCO

To the interview (in Swedish)

Cantargia partners up with pioneer within biotech industry

A brief introduction to Cantargia

To the interview

Press releases

2020-08-20 (R) Cantargia publishes half year report

2020-07-31 (R) New number of shares and votes in Cantargia

2020-06-23 (R) Cantargia strengthens management team with VP Regulatory Affairs and VP CMC

(R) = Regulatory press releases

”During 2018, we concluded the first very important part of the clinical development of CAN04 and presented patient data that strengthens our hopes that CAN04 can become an important part of tomorrow’s cancer treatment”

Göran Forsberg

CEO Cantargia

I am an investor

I want to know more about Cantargia's research

I want to know more about Cantargia as a company

CEO presentation

Presentation at ASCO 2019, follow up articles and interviews

Cantargia interview at EFN after ASCO

Cantargia partners up with pioneer within biotech industry

A brief introduction to Cantargia

2020-08-20 (R) Cantargia publishes half year report

2020-07-31 (R) New number of shares and votes in Cantargia

2020-06-23 (R) Cantargia strengthens management team with VP Regulatory Affairs and VP CMC

2020-08-21, Redeye analysis of Cantargia (in Swedish)

2020-08-21, Nordea analysis of Cantargia

2020-07-07, Aktiespararna analysis of Cantargia (In Swedish)

2020-05-28, Nordea analysis of Cantargia

2020-09-14, Video, H.C. Wainwright 22nd Annual Global Investment Conference

2020-09-14, Presentation, H.C. Wainwright 22nd Annual Global Investment Conference

2020-09-03, Presentation, Pareto Securities Annual Health Care Conference, Stockholm

2020-08-20, Video, Interview with CEO Göran Forsberg, Redeye (In Swedish)